Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
http://www.dddmag.com/printpdf/news/2015/01/intellicell-biosciences-licenses-indication-diabetes-invigorcell
IntelliCell BioSciences Licenses Indication for
Diabetes to Invigorcell
IntelliCell BioSciences
IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company"), a regenerative medicine
company utilizing adult autologous stromal vascular cells (SVCs) derived from the
blood vessels found in adipose tissue, announced a license agreement for the
indication of Diabetes Mellitus.
Invigorcell will be filing an IND with the FDA for the indication of Diabetes Mellitus.
According to Dr. Steven Victor CEO, "We are pleased to license the indication of
Diabetes Mellitus to Invigorcell who will be conducting an IND with the FDA. With Joe
Krivulka and Marc Sandberg MD leading the way I am sure we will see positive
results with the FDA in a short period of time, and be able to change the lives of
millions of diabetic patients."
Marc Sandberg, M.D., "Diabetes has both a huge financial and personal burden
around the world. Restoring both Beta Cell and Metabolic function using Stromal
Vascular Fraction Cells derived from blood vessels found in adipose tissue has a
great potential to relieve suffering of people and improve economies."
Source:
IntelliCell BioSciences
[1]
Source URL (retrieved on
01/28/2015 - 8:12pm
):
http://www.dddmag.com/news/2015/01/intellicell-biosciences-licenses-indication-
diabetes-invigorcell
Links:
[1] http://www.intellicellbiosciences.com
Folks are clearing for 100% gains. 5000% coming.
Spread is tightening. Wonder why
...
I sold 4000 shares for a loss.
Feeling dumb.
Holding 14,000 more, though. If she breaks .52, I will thank my lucky stars.
Wow! I KNEW I should have sold my losers. My guess: Winter is coming! More flu. More colds. More viruses. More measles
This news is HUGE!!!!!!
Something is up. Thank goodness!
OFCN? I could not find this ticker. :(
This chart looks like we are headed to twenty cents in no time.
I'm holding my 104,500 shares like a vise grip.
$$$$$$$$$$$$$$$850,000,000 in revs.
As for profits, the forthcoming ROG deal is 200 million, but 50 million is allocated to Innovative Trailer Design, and, of course, Dell will get a cut as well.
I would surmise that profit margins would be between 25-35% because they will have to pay for local healthcare workers.
Dollar bound!
imo
Check out $KALO's 8K today, my friend. Buy some and stay for a bit.
Nothing like $860,000,000 in revenue. It's coming.
250 million :)
Lagos, Nigeria (PANA) - The regional war against malaria being waged by ECOWAS and partners, through the biolarvicide programme, moves to Ghana this week with a ground-breaking ceremony Tuesday for the construction of a factory in the capital city of Accra for the production of the substance.
Ahead of the ceremony, a tripartite experts working group meeting was held in Accra by ECOWAS, Cuba and Venezuela on Monday (5Aug), to discuss, among others, the feasibility study, cost build up and investment architecture of the project as well as the forthcoming 4th High-Level partners meeting in Venezuela.
The biolarvicide programme, which is being held within the framework of the Campaign for the Elimination of Malaria in West Africa by 2015, will bring together health experts from within and outside the ECOWAS region.
The President of Ghana, the country’s Health Minister as well as the President of the ECOWAS Commission are among important dignitaries expected to grace the event.
The Accra factory is one of the three being constructed in the region under a tripartite agreement involving ECOWAS, Cuba and Venezuela.
The ground-breaking ceremonies for the other two have been held in Cote d’Ivoire and Port Harcourt, Nigeria.
The regional campaign seeks to free the region from the malaria scourge that kills thousands of people in Africa every year and costs the continent more than US$12 billion annually.
Under the regional campaign focused on the strengthening of the vector control component, recognised internationally as the only intervention that can reduce malaria transmission from high level to zero, Cuba and Venezuela are providing the financial support, technical know-how and technology transfer to make readily available in the region, biolarvicide, the substance that destroys mosquitoes, the malaria vectors, in their larvae stage of development.
This is with the purpose of bolstering the elimination campaign through massive larviciding/spraining across the region. Similar
campaigns have yielded resounding successes in Latin America and other parts of the world.
PANA quotes the ECOWAS Commission as saying that West Africa bears the heaviest burden of malaria in Africa, with the disease stunting the economic development of the region and the continent as a whole.
-0- PANA ST/SEG 5Aug2013
05 august 2013 14:06:33
http://ecowas.int/
FYI:
That chart looked ripe for a reason.
KALO HAD news just before market closed! Put it on watch first thing in the morning!
NEWS:
http://otcmarkets.com/edgar/GetFilingHtml?FilingID=10429807
Funding for US$ 795 Million Kallo project in final discussions. – Ghana Ministry of Health.
NEW YORK, NY – January 27, 2015 Kallo Inc. (OTC QB: KALO) Kallo Inc. announced today that the office of the Minister of Finance – Ghana has been presented an offer to finance healthcare projects in Ghana valued at Euros 850 million. 250 million euros is to be utilized for a nation-wide malaria vector larviciding program, and the balance 600 million euros is for the Nation wide deployment of Kallo MobileCare, RuralCare and DialysisCare programs from Kallo Inc.
Mr. John Cecil, Chairman and CEO of Kallo Inc. said, "We have been working very diligently and tenaciously over the past several months to bring the deployment of Kallo programs to fruition in Ghana. This development is a major step in bringing us closer to implementation."
Kallo has been working with the Government of Ghana and specifically with the ministry of health since 2012 when the first presentation was made and a MOU signed.
"At the request of the Ministry of Health of Ghana, I will be visiting Accra once again to meet and discuss with the Ministries of Health and finance. I look forward to concluding all discussions and commencing the implementation of Kallo programs." Continued Mr. Cecil.
Looks interesting. I have put half my $$$ im KALO. Check out my posts over there. Not a small float, but a billion in revs coming.
This one is a keeper.
R XMD. CHECK OUT
The Ichims do well if they vest. This is an incentive to produce. Buying more.
Still seems undervalued relative to potential.
My only headache now is whether to sell stocks on the red and move to RXMD, a tiny co. with 9 million in revs, or wait for them to bounce. Decisions!
I know that Intellicell helped regrow heart musle and improved ejection fraction.
Pretty cool right there!
Agreed. Pepe has worked hard to create value-imo. Looking forward to seeing green again in my IRA.
I haven't been able go figure this out. Anyone elsr?
Tarpon has likely been releasing shares since September. There's always a risk of a pump and dump--but Progressive has lived up to its name--leveraging the prospect of a zero balance sheet to find Joint Ventures. Add to this, an ever present increase in potential customers who are denied TamiFlu at CVS or Walgreens's, and suddenly, Progressive is a viable alternative that will deliver to your door, thus limiting your contact with people when you are contagious or when you don't want to be exposed to other germs while you're down.
In Charlotte, NC, many of my friends are now having difficulty finding TamiFlu--but the Private Pharmacy put out a banner "We Have TamiFlu HERE!"
I think if we all continue to tout this company, investors will smell opportunity.
I still see this stock at a quarter by the end of next month.
Small time investor here with 42,000 shares--but buying more next week.
all imo
You know, I sometimes get the feeling that Kallo wants to keep the stock low--to benefit Kodiak. My feeling is that the CEO understands the limitations of penny world--and will release the grandadddy of all PRs--Major Revenues. I would expect the share price to rocket to .46 (52 week high), where the put would execute--and Kodiak would also likely sell into the initial surge.Trade sideways and then repeat at next PR--until stock climbs into dollar land.
But, I think management is giving longs enough hints to keep us in the loop. Check this LinkedIn link from IDT. The company has hired a new HR Manager--Gee, I wonder why they need a new, experienced HR man? Could it be that they expect to grow exponentially--requiring more hires than the owner, Ben, can possibly manage?
And...I am in no way associated with this company, but I do like the potential and have invested a nice chunk of change in it. Demonstrating patience is difficult, especially when other stocks I own--like RXM$--goes up 150% in a couple weeks. But, I am trying to be patient with Kallo; it is, after all, closely linked with the OIL sector. It might Ghana a little extra while to pony up, but I believe they will eventually.
Best wishes to all!
https://www.linkedin.com/company/innovative-trailer-design-industries-inc.
all IMO
Though I sold at a profit months ago, I have learned that Otc is for short term trading only. I am sorry for those who must take a loss here. I sold the day I found out Michery registered shares for a private co. in the same line of the business. What a disappointment! Imo
Hey-
I saw what looked like dilution and got the heck out.
Took a couple hundred loss. Pu my $$ into R(ex)MD.
.15-.30
.25-.50 if. 01
So, if they eek out a half pence profit, you are suggesting. 25-.50--correct? More powder coming tomorrow from me.
I just bought 28,000 more. Headed to a half dollar!!!!!!
Ichims will make serious bank with IND approval.
Pennyland
...that woulf be nice. I like green.
Well...Big G is growing the company and is striving for market share
The widgets are real. I see they sell on Amazon, so I know it's not a scam. As long as dilution is controlled and used to fund more strategic partnerships, then yes I am cool. Bought 100,000 more.
9,000,000 in revs and paying doen debt and joint venture and flu epidemic hitting old folks. We should be punching a half dollar.
Up 20%
Hey-
I lost a little with the split, but when I see the founder of this Gig-It game's hanging with the sister of Facebook's Zuckerburg, I get excited.
No one here is buying the company; I bought the buyout potential.
http://everything-pr.com/randi-zuckerbergs-gig-it-celeb-game-gets-hip-hop-pr-sendoff/242194/
NEWS!!!
My teens love GigIt!!!!!!!!!!!!!!!!!
Nyxio Takes Play Gig-it to Mobile
Back
Marketwire via COMTEX - Tue Jan 20, 09:00AM CST
Nyxio Technologies Corporation ( OTC PINK : NYXO ) Nyxio's Play Gig-it will go mobile with the help of Diyi Technologies based out of China and the United States. Play Gig-it allows users to select their favorite music artist and design a concert for real-time interaction with their friend networks. Diyi rendered back-end software for the Play Gig-it game platform in its early stages in 2010 through 2012 and has deep familiarity with the company's design and coding protocols. Paul Duan, Founder of Diyi, states, "It has been a pleasure working with Nyxio over the past few months in preparation of taking terabytes of code and data and prepping it for a fast, proprietary high definition application. Play Gig-it's real time 3D animation revolutionized the virtual simulation market creating a breathtaking user experience. The mobile platform will allow users to not only create unique concerts but will allow them to be shared via text based messaging, and with all existing social networks."
In late December, 2014, Nyxio announced Play Gig-it's partnership with TopFan, which would enable them to create custom mobile applications for over 175 artists and celebrities. Nyxio CEO Giorgio Johnson states, "Our acquisition of Play Gig-it was paramount for our foray into mobile markets. Bringing in Diyi Technologies affords us the ability to expand further into the flourishing viral mobile environment." Johnson continues, "The core of the product allows us to enter the social music distribution and streaming business with a roster of over 70 Major recording artists and the support of 175 artists and celebrities with our recently announced partnership with TopFan. There are thousands of social platforms, and none have our groundbreaking technology." Johnson concludes, "Our Play Gig-it mobile application will demonstrate our ability to create great user experience mobile products and usher in our 2015 launch campaign. By creating the largest Celebrity endorsed mobile application platform in the world, Nyxio is positioned to further its advance into the mobile gaming and advertising markets."
About Nyxio Technologies ( OTC PINK : NYXO ):
Founded in 2007, Nyxio® Technologies Corporation ( OTC PINK : NYXO ) designs and markets a line of innovative consumer electronics devices to deliver high-quality, cutting-edge products to consumers and businesses. The company is known for its innovative products that offer distinctive features such as touch screen controls, built-in Bluetooth capabilities, wireless and video features all bundled into practical and inventive packages. The company introduced VuzionT the first AndroidT OS television and the VioSphere an integrated flat screen Smart TV and full PC. Other products currently available include the OMEGA Tablet PC line the Classic, Premier and Ultimate, as well as the Realm, an all-in-one PC/TV, the Realm Pro, digital signage and B2B solution and the Venture Mobile Media Viewers (MMV), a new class of video eyewear. By consolidating key hardware into more efficient devices, Nyxio not only reduces the overall environmental footprint of end users, but also keeps products reasonably priced. For more information visit: www.nyxio.com .
Notice Regarding Forward-Looking Statements:
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this news release, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact
Lorien Sekora
(503) 333-5974
© 2015 Marketwire L.P. All rights reserved.
Holding long since I bought at a dime. In my IRA!
http://www.wsvn.com/story/27785751/vatican-earmarks-355-million-for-ebola-care
I hope Kallo can cash in.
I only have a small position at 14,500 shares, but I'm holding for a while.